摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,6-dichloro-4-(2-ethyl-1,3-dioxolan-2-yl)pyridine | 183433-63-8

中文名称
——
中文别名
——
英文名称
2,6-dichloro-4-(2-ethyl-1,3-dioxolan-2-yl)pyridine
英文别名
——
2,6-dichloro-4-(2-ethyl-1,3-dioxolan-2-yl)pyridine化学式
CAS
183433-63-8
化学式
C10H11Cl2NO2
mdl
——
分子量
248.109
InChiKey
ODMWILSLLPWFPQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    31.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2,6-dichloro-4-(2-ethyl-1,3-dioxolan-2-yl)pyridine 在 palladium on activated charcoal palladium diacetate 、 2,2,6,6-tetramethyl-piperidine-N-oxyl 、 sodium hypochlorite 、 sodium tetrahydroborate 、 四氧化锇正丁基锂三甲基氯硅烷4-acetoxy-2,2,6,6-tetramethylpiperidine-1-oxyl十二/十四烷基二甲基氧化胺 、 PS-30 catalyst 、 巴拉松potassium tert-butylate四丁基氯化铵氢气碳酸氢钠potassium carbonatecaesium carbonate对甲苯磺酸 、 sodium iodide 、 potassium bromide 作用下, 以 四氢呋喃甲醇二氯甲烷溶剂黄146二甲基亚砜N,N-二甲基甲酰胺甲苯乙腈三氟乙酸叔丁醇 为溶剂, -30.0~110.0 ℃ 、103.42 kPa 条件下, 反应 274.67h, 生成 7-乙基-10-羟基喜树碱
    参考文献:
    名称:
    Practical Asymmetric Synthesis of (S)-4-Ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine- 3,6,10(4H)-trione, a Key Intermediate for the Synthesis of Irinotecan and Other Camptothecin Analogs
    摘要:
    A practical asymmetric synthesis of(S) 4-ethyl-7,8-dihydro -4-hydroxy-1H-pyrano[3, 4-f]indolizine-3,6,10(4H)-trione (1), a versatile intermediate for the synthesis of camptothecin analogs, was developed. Commercially available citrazinic acid is converted in four steps into the 2-chloro-6-methoxypyridine 5. An ortho-directed metalation followed by reaction with a formamide produces an aldehyde with the required 2,3,4,6-substituted pyridine (6) with high regioselectivity. After refunctionalization of the aldehyde, the chloropyridine is converted into an ester by a facile palladium-mediated carbonylation reaction. Wittig reaction and racemic osmylation produce the diol 16 which is resolved by an efficient lipase resolution to an ee > 99%, and a one-pot recycle of the unwanted diol enantiomer was developed. A series of high-yielding oxidation and deprotection steps convert (S)-16 into the pyridone 25, which is then converted into 1 with an ee > 99.6%.
    DOI:
    10.1021/jo970173f
  • 作为产物:
    描述:
    柠嗪酸三甲基氯硅烷 、 POPCl3四甲基氯化铵 作用下, 以 四氢呋喃 为溶剂, 反应 15.0h, 生成 2,6-dichloro-4-(2-ethyl-1,3-dioxolan-2-yl)pyridine
    参考文献:
    名称:
    Practical Asymmetric Synthesis of (S)-4-Ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine- 3,6,10(4H)-trione, a Key Intermediate for the Synthesis of Irinotecan and Other Camptothecin Analogs
    摘要:
    A practical asymmetric synthesis of(S) 4-ethyl-7,8-dihydro -4-hydroxy-1H-pyrano[3, 4-f]indolizine-3,6,10(4H)-trione (1), a versatile intermediate for the synthesis of camptothecin analogs, was developed. Commercially available citrazinic acid is converted in four steps into the 2-chloro-6-methoxypyridine 5. An ortho-directed metalation followed by reaction with a formamide produces an aldehyde with the required 2,3,4,6-substituted pyridine (6) with high regioselectivity. After refunctionalization of the aldehyde, the chloropyridine is converted into an ester by a facile palladium-mediated carbonylation reaction. Wittig reaction and racemic osmylation produce the diol 16 which is resolved by an efficient lipase resolution to an ee > 99%, and a one-pot recycle of the unwanted diol enantiomer was developed. A series of high-yielding oxidation and deprotection steps convert (S)-16 into the pyridone 25, which is then converted into 1 with an ee > 99.6%.
    DOI:
    10.1021/jo970173f
点击查看最新优质反应信息

文献信息

  • Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents
    作者:Feijie Xu、Wenlong Li、Wen Shuai、Limei Yang、Yi Bi、Cong Ma、Hequan Yao、Shengtao Xu、Zheying Zhu、Jinyi Xu
    DOI:10.1016/j.ejmech.2019.04.008
    日期:2019.7
    derivatives as potential anti-tubulin agents. All the target compounds were evaluated for their antiproliferative activities. Among them, representative compound 16f exhibited the most potent activity with the IC50 values ranging from 0.023 to 0.045 μM against a panel of cancer cell lines. Further mechanism study results demonstrated that compound 16f effectively inhibited the microtubule polymerization by binding
    通过引入吡啶环进一步优化母体查尔酮化合物(2a)的三甲氧基苯基骨架,提供了一系列新型的吡啶-查尔酮衍生物作为潜在的抗微管蛋白剂。评价所有目标化合物的抗增殖活性。其中,代表性的化合物16F显示出与IC的最有效的活性50值范围从0.023至0.045  μ中号针对癌细胞系的面板。进一步的机理研究结果表明,化合物16f通过与微管蛋白的秋水仙碱位点结合,有效抑制了微管聚合。此外,细胞机制研究显示16f导致G2 / M期停滞,诱导细胞凋亡并破坏细胞内微管网络。同样,16f减少了细胞迁移并破坏了人脐静脉内皮细胞(HUVEC)的毛细血管样形成。重要的是,16f在H22异种移植模型中显着抑制了肿瘤的生长,而没有明显的毒性,它比参考化合物CA-4强,这表明值得研究16f作为有效的微管去稳定剂用于癌症治疗。
  • 吡啶取代查尔酮类化合物或其可药用的盐及其制备方法和用途
    申请人:中国药科大学
    公开号:CN109535068B
    公开(公告)日:2022-07-29
    本发明公开了具有通式I所示结构的吡啶取代查尔酮类化合物或其可药用的盐,还公开了上述化合物或其可药用的盐的制备方法及用途。本发明的化合物或其可药用的盐毒副作用小,水溶性强,不易产生耐药性,可有效地抑制微管蛋白的聚集,并具有较强的体外及体内抗肿瘤活性,其代谢更为稳定,成药性前景好。本发明也包括联合应用吡啶取代查尔酮类化合物或其可药用的盐与TACC3抑制剂有效抑制对微管蛋白耐药的肿瘤细胞活性。其中,。
  • Practical Asymmetric Synthesis of (<i>S</i>)-4-Ethyl-7,8-dihydro-4-hydroxy-1<i>H</i>-pyrano[3,4-f]indolizine- 3,6,10(4<i>H</i>)-trione, a Key Intermediate for the Synthesis of Irinotecan and Other Camptothecin Analogs
    作者:Kevin E. Henegar、Scott W. Ashford、Ted A. Baughman、John C. Sih、Rui-Lin Gu
    DOI:10.1021/jo970173f
    日期:1997.9.1
    A practical asymmetric synthesis of(S) 4-ethyl-7,8-dihydro -4-hydroxy-1H-pyrano[3, 4-f]indolizine-3,6,10(4H)-trione (1), a versatile intermediate for the synthesis of camptothecin analogs, was developed. Commercially available citrazinic acid is converted in four steps into the 2-chloro-6-methoxypyridine 5. An ortho-directed metalation followed by reaction with a formamide produces an aldehyde with the required 2,3,4,6-substituted pyridine (6) with high regioselectivity. After refunctionalization of the aldehyde, the chloropyridine is converted into an ester by a facile palladium-mediated carbonylation reaction. Wittig reaction and racemic osmylation produce the diol 16 which is resolved by an efficient lipase resolution to an ee > 99%, and a one-pot recycle of the unwanted diol enantiomer was developed. A series of high-yielding oxidation and deprotection steps convert (S)-16 into the pyridone 25, which is then converted into 1 with an ee > 99.6%.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-